What Researchers Did
Researchers conducted a prospective, randomized controlled trial to compare the incidence of delayed neurologic sequelae in patients with mild to moderate carbon monoxide poisoning treated with either ambient pressure oxygen or hyperbaric oxygen.
What They Found
Delayed neurologic sequelae (DNS) developed in 7 of 30 patients (23%) treated with ambient pressure oxygen, compared to 0 of 30 patients treated with hyperbaric oxygen (P < .05). DNS typically appeared 6 days after poisoning and lasted for an average of 41 days.
What This Means for Canadian Patients
Canadian patients experiencing mild to moderate carbon monoxide poisoning may benefit from hyperbaric oxygen therapy to significantly reduce the risk of developing delayed neurological problems. This treatment could help prevent long-term cognitive issues that might otherwise emerge weeks after the initial poisoning.
Canadian Relevance
There is no direct Canadian connection mentioned in the study metadata or abstract.
Study Limitations
The study's findings are limited by its relatively small sample size and focus on patients with mild to moderate carbon monoxide poisoning.